Fracture risk prediction in postmenopausal women from GO Study: the comparison between FRAX, Garvan, and POL-RISK algorithms

Summary In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresh...

Full description

Saved in:
Bibliographic Details
Published inArchives of osteoporosis Vol. 19; no. 1; p. 39
Main Authors Pluskiewicz, W., Werner, A., Bach, M., Adamczyk, P., Drozdzowska, B.
Format Journal Article
LanguageEnglish
Published London Springer London 16.05.2024
Subjects
Online AccessGet full text
ISSN1862-3514
1862-3522
1862-3514
DOI10.1007/s11657-024-01392-5

Cover

Abstract Summary In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators. Introduction The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence. Material The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years. Results During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools. Conclusion The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures.
AbstractList In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators.In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators.The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence.INTRODUCTIONThe aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence.The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years.MATERIALThe study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years.During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools.RESULTSDuring the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools.The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures.CONCLUSIONThe current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures.
In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators. INTRODUCTION: The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence. MATERIAL: The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years. RESULTS: During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools. CONCLUSION: The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures.
Summary In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators. Introduction The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence. Material The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years. Results During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools. Conclusion The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures.
In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators. The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence. The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years. During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools. The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures.
ArticleNumber 39
Author Drozdzowska, B.
Pluskiewicz, W.
Werner, A.
Adamczyk, P.
Bach, M.
Author_xml – sequence: 1
  givenname: W.
  orcidid: 0000-0003-1839-6560
  surname: Pluskiewicz
  fullname: Pluskiewicz, W.
  email: wpluskiewicz@sum.edu.pl
  organization: Department and Clinic of Internal Diseases, Diabetology, and Nephrology, Metabolic Bone Diseases Unit, Faculty of Medical Sciences in Zabrze, Medical University of Silesia
– sequence: 2
  givenname: A.
  orcidid: 0000-0001-6098-0088
  surname: Werner
  fullname: Werner, A.
  organization: Department of Applied Informatics, Silesian University of Technology
– sequence: 3
  givenname: M.
  orcidid: 0000-0002-6239-7790
  surname: Bach
  fullname: Bach, M.
  organization: Department of Applied Informatics, Silesian University of Technology
– sequence: 4
  givenname: P.
  orcidid: 0000-0001-9557-221X
  surname: Adamczyk
  fullname: Adamczyk, P.
  organization: Department of Pediatrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia
– sequence: 5
  givenname: B.
  orcidid: 0000-0002-2287-6842
  surname: Drozdzowska
  fullname: Drozdzowska, B.
  organization: Department of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38755326$$D View this record in MEDLINE/PubMed
BookMark eNqFks1rFDEAxYNU7If-Ax4kRw-dmo9JMuNFSnG3xYWVVsFbyGaS3dSZZEwyLQX_eLNuK9VDPSUh7_d48N4h2PPBGwBeY3SCERLvEsaciQqRukKYtqRiz8ABbjipKMP13qP7PjhM6RohjjDjL8A-bQRjlPAD8HMWlc5TNDC69B2O0XROZxc8dB6OIeXB-DCqKake3obygDaGAc6X8CpP3d17mDcG6jCMqvCFWpl8a4pqdnn67RjOVbxR_hgq38HPy0V1eXH1Cap-HaLLmyG9BM-t6pN5dX8ega-zj1_OzqvFcn5xdrqodN2gXFluVwRZjTva1pStVEs7jrUmjDRYNF1jlSa07jjVnBlkqaopbik1thUW8ZYegQ8733FaDabTxueoejlGN6h4J4Ny8u8f7zZyHW4kxqhtGiGKw9t7hxh-TCZlObikTd8rb8KUJMWMcsGFYP-XIsY5x4LWRfrmca4_gR7qKYJmJ9AxpBSNldplta2nxHS9xEhulyB3S5BlCfL3EuQ2BvkHfXB_EqI7KBWxX5sor8MUfenmKeoXpxHGTA
CitedBy_id crossref_primary_10_4239_wjd_v15_i9_1962
Cites_doi 10.1111/ijcp.14009
10.1007/s00198-019-05088-2
10.1007/s11606-018-4696-z
10.1097/MD.0000000000003415
10.1007/s00198-007-0362-8
10.1016/j.afos.2018.03.001
10.1002/jbmr.371
10.1007/s00198-019-04919-6
10.1136/bmj.i6755
10.1016/j.bone.2010.02.012
10.1016/j.jocd.2017.06.023
10.1002/jbmr.215
10.5603/EP.2017.0062
10.1136/bmjopen-2021-060282
10.1007/s00198-021-05941-3
10.1002/jbmr.1956
10.1007/s00198-007-0543-5
10.1016/j.maturitas.2015.12.003
10.1359/jbmr.2000.15.4.721
10.1002/jbm4.10532
10.1002/jbmr.4432
10.1016/j.maturitas.2013.10.021
10.1016/j.jocd.2017.07.005
10.1007/s11657-023-01346-3
10.1007/s00198-008-0588-0
10.3109/13685538.2013.875991
10.20452/pamw.16395
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOI 10.1007/s11657-024-01392-5
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
AGRICOLA

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1862-3514
EndPage 39
ExternalDocumentID PMC11098877
38755326
10_1007_s11657_024_01392_5
Genre Journal Article
Comparative Study
GroupedDBID ---
-5E
-5G
-BR
-EM
-~C
.VR
06C
06D
0R~
0VY
1N0
203
23N
29~
2J2
2JN
2KG
2KM
2LR
2~H
30V
4.4
406
408
40D
53G
5GY
67Z
6NX
875
8TC
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANZL
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACCUX
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACSNA
ACZOJ
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BGNMA
BSONS
C6C
CS3
CSCUP
DDRTE
DNIVK
DPUIP
EBLON
EBS
EIOEI
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
IZQ
J-C
J0Z
JBSCW
JZLTJ
KDC
KOV
LLZTM
M4Y
NPVJJ
NQJWS
NU0
O93
O9I
O9J
P2P
P9S
PF0
PT4
QOR
QOS
R89
R9I
RPX
RSV
S16
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
TSG
TSK
TT1
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WK8
YLTOR
Z45
Z7U
Z87
ZMTXR
ZOVNA
~A9
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
EMOBN
ROL
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c480t-f6fb20fc1d39435ba93d61cc2528178d8fac234d63c65e0f3a431933ef97f0693
IEDL.DBID U2A
ISSN 1862-3514
1862-3522
IngestDate Thu Aug 21 18:35:38 EDT 2025
Fri Aug 22 20:23:37 EDT 2025
Tue Aug 05 09:48:47 EDT 2025
Mon Jul 21 06:01:38 EDT 2025
Tue Jul 01 01:01:07 EDT 2025
Thu Apr 24 23:07:29 EDT 2025
Fri Feb 21 02:36:13 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Women
Osteoporosis
FRAX
Fracture prediction
POL-RISK
Garvan
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c480t-f6fb20fc1d39435ba93d61cc2528178d8fac234d63c65e0f3a431933ef97f0693
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-6098-0088
0000-0001-9557-221X
0000-0003-1839-6560
0000-0002-6239-7790
0000-0002-2287-6842
OpenAccessLink https://link.springer.com/10.1007/s11657-024-01392-5
PMID 38755326
PQID 3056661734
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11098877
proquest_miscellaneous_3153676775
proquest_miscellaneous_3056661734
pubmed_primary_38755326
crossref_citationtrail_10_1007_s11657_024_01392_5
crossref_primary_10_1007_s11657_024_01392_5
springer_journals_10_1007_s11657_024_01392_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-05-16
PublicationDateYYYYMMDD 2024-05-16
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-16
  day: 16
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Archives of osteoporosis
PublicationTitleAbbrev Arch Osteoporos
PublicationTitleAlternate Arch Osteoporos
PublicationYear 2024
Publisher Springer London
Publisher_xml – name: Springer London
References MG Donaldson (1392_CR7) 2011; 26
ND Nguyen (1392_CR4) 2008; 19
L Iconaru (1392_CR23) 2022; 37
C Beaudoin (1392_CR9) 2019; 30
W Pluskiewicz (1392_CR14) 2014; 17
1392_CR6
ND Nguyen (1392_CR3) 2007; 18
G Todorow (1392_CR22) 2022; 12
W Pluskiewicz (1392_CR25) 2021; 32
KH Rubin (1392_CR8) 2013; 28
JA Kanis (1392_CR2) 2008; 19
1392_CR27
MJ Bolland (1392_CR15) 2011; 26
N Dagan (1392_CR21) 2017; 356
R Lorenc (1392_CR26) 2017; 68
KL Holloway-Kew (1392_CR19) 2019; 30
CM Klotzbuecher (1392_CR1) 2000; 15
CJ Crandall (1392_CR18) 2018; 34
TV Nguyen (1392_CR11) 2017; 20
TACM van Geel (1392_CR16) 2014; 77
SY Chen (1392_CR10) 2016; 95
W Pluskiewicz (1392_CR28) 2023; 18
W Pluskiewicz (1392_CR13) 2010; 46
P Adamczyk (1392_CR5) 2018; 21
F Baleanu (1392_CR20) 2021; 5
EO Billington (1392_CR17) 2016; 85
TV Nguyen (1392_CR12) 2018; 4
W Pluskiewicz (1392_CR24) 2021; 75
References_xml – volume: 75
  start-page: 14009
  year: 2021
  ident: 1392_CR24
  publication-title: Int J Clin Pract
  doi: 10.1111/ijcp.14009
– volume: 30
  start-page: 2129
  year: 2019
  ident: 1392_CR19
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-019-05088-2
– volume: 34
  start-page: 235
  year: 2018
  ident: 1392_CR18
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-018-4696-z
– volume: 95
  start-page: e3415
  issue: 20
  year: 2016
  ident: 1392_CR10
  publication-title: Medicine
  doi: 10.1097/MD.0000000000003415
– volume: 18
  start-page: 1109
  year: 2007
  ident: 1392_CR3
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-007-0362-8
– volume: 4
  start-page: 2
  year: 2018
  ident: 1392_CR12
  publication-title: Osteoporosis and Sarcopenia
  doi: 10.1016/j.afos.2018.03.001
– volume: 26
  start-page: 1767
  year: 2011
  ident: 1392_CR7
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.371
– volume: 30
  start-page: 721
  year: 2019
  ident: 1392_CR9
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-019-04919-6
– volume: 356
  start-page: i6755
  year: 2017
  ident: 1392_CR21
  publication-title: BMJ
  doi: 10.1136/bmj.i6755
– volume: 46
  start-page: 1661
  year: 2010
  ident: 1392_CR13
  publication-title: Bone
  doi: 10.1016/j.bone.2010.02.012
– volume: 20
  start-page: 368
  year: 2017
  ident: 1392_CR11
  publication-title: J Clin Densitom
  doi: 10.1016/j.jocd.2017.06.023
– volume: 26
  start-page: 420
  year: 2011
  ident: 1392_CR15
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.215
– volume: 68
  start-page: 1
  year: 2017
  ident: 1392_CR26
  publication-title: Endokrynol Pol
  doi: 10.5603/EP.2017.0062
– ident: 1392_CR27
– volume: 12
  start-page: e060282
  year: 2022
  ident: 1392_CR22
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2021-060282
– volume: 32
  start-page: 2043
  year: 2021
  ident: 1392_CR25
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-021-05941-3
– volume: 28
  start-page: 1701
  year: 2013
  ident: 1392_CR8
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.1956
– volume: 19
  start-page: 385
  year: 2008
  ident: 1392_CR2
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-007-0543-5
– volume: 85
  start-page: 11
  year: 2016
  ident: 1392_CR17
  publication-title: Maturitas
  doi: 10.1016/j.maturitas.2015.12.003
– volume: 15
  start-page: 721
  year: 2000
  ident: 1392_CR1
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.2000.15.4.721
– volume: 5
  start-page: e10532
  issue: 9
  year: 2021
  ident: 1392_CR20
  publication-title: JBMR Plus (WOA)
  doi: 10.1002/jbm4.10532
– volume: 37
  start-page: 59
  year: 2022
  ident: 1392_CR23
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.4432
– volume: 77
  start-page: 174
  year: 2014
  ident: 1392_CR16
  publication-title: Maturitas
  doi: 10.1016/j.maturitas.2013.10.021
– volume: 21
  start-page: 213
  issue: 2
  year: 2018
  ident: 1392_CR5
  publication-title: J Clin Densitom
  doi: 10.1016/j.jocd.2017.07.005
– volume: 18
  start-page: 136
  issue: 1
  year: 2023
  ident: 1392_CR28
  publication-title: Arch Osteoporos
  doi: 10.1007/s11657-023-01346-3
– volume: 19
  start-page: 1431
  year: 2008
  ident: 1392_CR4
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-008-0588-0
– volume: 17
  start-page: 174
  year: 2014
  ident: 1392_CR14
  publication-title: Aging Male
  doi: 10.3109/13685538.2013.875991
– ident: 1392_CR6
  doi: 10.20452/pamw.16395
SSID ssj0060156
Score 2.3197327
Snippet Summary In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a...
In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 39
SubjectTerms Absorptiometry, Photon - statistics & numerical data
Aged
Algorithms
Bone Density
densitometry
Endocrinology
Female
femur
Humans
Incidence
Longitudinal Studies
Medicine
Medicine & Public Health
Middle Aged
Original
Original Article
Orthopedics
osteoporosis
Osteoporosis, Postmenopausal - complications
Osteoporosis, Postmenopausal - epidemiology
Osteoporotic Fractures - epidemiology
Postmenopause
prediction
Retrospective Studies
risk
risk assessment
Risk Assessment - methods
Risk Factors
Sensitivity and Specificity
therapeutics
Title Fracture risk prediction in postmenopausal women from GO Study: the comparison between FRAX, Garvan, and POL-RISK algorithms
URI https://link.springer.com/article/10.1007/s11657-024-01392-5
https://www.ncbi.nlm.nih.gov/pubmed/38755326
https://www.proquest.com/docview/3056661734
https://www.proquest.com/docview/3153676775
https://pubmed.ncbi.nlm.nih.gov/PMC11098877
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBdrC2MvY91X021Bg70tAsv6sLy3NNTp1rUd3QLZk5FkaQ20ToiTh0H_-OocOyXtCOzJD5ZkrJPufsfd_Q6hT4mizCdGEOM0IzyxjgQr54hMeWypNEKmUOB8di5PRvzbWIyborCqzXZvQ5K1pr4vdqNSJCTYFAKwJbhQO2hPBN8druMo7rf6V0JxcFMe8-95myboEa58nB75IEZam57sBXreYEbcXwl5Hz1x5Uv09KyJir9CtxmUOi3nDkOiOJ7N4Q1sOJ6UeDatIJE8-MbLKixSMy5gKCrBwwsMWYR_v-AAArFdNyTETe4Wzi774x4eQvegsod1WeAfF9_J5defp1hf_5nOJ4urm-o1GmXHvwYnpOmqQCxX0YJ46U0ceUsLlgasZHTKCkmtjUWsaKIK5bWNGS8ks1K4yDMdMEbKmPNp4iOZsjdot5yW7gBho1KlpNJGc8-1jrQWnFtXUKZNKgvXQbTd6Nw2lOPQ-eI6vydLBuHkQTh5LZxcdNDn9ZzZinBj6-iPrfzycC8g2KFLN11WObhGAXskjG8ZE9Q9ENYlYZ23K5mvv8mCIycCtu0gtXEa1gOAl3vzTTm5qvm5gcQ16O6kg3rtwckbzVBt-ZfD_xv-Dj2L60MtCJXv0e5ivnQfAkBamC7a62dHR-fwHP4-Pe6inYEcdOtbcgcwLg1j
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDCa2FNh62Xtt9tSA3RYVtvWw3FswNEmXpB26BshOhiTLa9DOCWL7sGE_vpJjp0g7BOhZD1sSJX4EyY8An0PhkzRUDCsjCaahNthqOYN5RAPtc8V45BKcxyd8MKHfpmxaJ4XlTbR745KsXuqbZDefsxBbnYIdbLEm1EPYodYG91qw0-3_HB41LzB36cF1gsz_R24qoTvI8m6A5C0vaaV8ek9h0vz2Kubk8qAs1IH-e4vR8b7regZPajSKuivxeQ4PTPYCHo1rf_tL-NdzSVTl0iAXgo4WS9fijhLNMrSY5y5E3VrdZW4nqbgckEtXQf1T5OIT_xwiCy-RXpc6RHVUGOqddacd1Hd1ibIOklmCvp-O8NnxjyGSV7_my1lx8Tt_BZPe0fnXAa7rNWBNhVfglKcq8FLtJySyKEzJiCTc1zpggfBDkYhU6oDQhBPNmfFSIi16iQgxaRSmHo_Ia2hl88zsA1IiEoILqSRNqZSelIxSbRKfSBXxxLTBbw4w1jWZuaupcRXf0DC7bY3ttsbVtsasDV_WYxYrKo-tvT81chHbG-fcKDIz8zKPndFlUU1I6JY-VpE4KrzQzrO3kqX1N4k1EZlFzW0QG1K27uAYvzdbstlFxfzt6GGtVgjb0GlkKa7fnHzLWt7cr_tHeDw4H4_i0fHJ8C3sBpVoMuzzd9AqlqV5b2FYoT7Ut-4aZH8pXw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELZgkVZcEG_K00jcqLVx_IjNrQKyu-xTC5V6i2zHZistadWkByR-PJ406VIWVeLssaN4xuPP8nyfEXqXKcpCZgWx3jDCM-dJ3OU8kZqnjkorpAaC88mpPBjzLxMx-YPF31a791eSK04DqDRVzd68DHvXxDcqRUbi_kIAwsTj1G10J6ZjCpE-Tkd9LpZAFO6oMv_ut7kd3cCYN0sl_7ovbbeh_D661-FHPFo5_AG65auHaPekuyF_hH7lQHtaLjyGonE8X0ALTD6eVng-q6GoPJ6Tl3UcpFVfwEAwwftnGCoKf37AERBit36cEHd1XDi_GE2GeB9eEqqG2FQlPj87JheHX4-wufo-W0ybyx_1YzTOP3_7eEC6FxaI4yppSJDBpklwtGQ64iZrNCsldS4VqaKZKlUwLmW8lMxJ4ZPATMQbmjEfdBYSqdkTtFPNKv8MYau0UlIZa3jgxiTGCM6dLykzVsvSDxDtJ7pwnfw4vIJxVVwLJ4NziuiconVOIQbo_brPfCW-sdX6be-_Iq4RuPgwlZ8t6wKOSRGHZIxvsYmpH8TrsjjO05XP199k8VAnIs4dILURDWsD0OjebKmml61WNwi6xjyeDdCwD5yiyxL1ln95_n_mb9Du-ae8OD48PXqB7qZtfAtC5Uu00yyW_lXETY193S6N3_jmEKU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fracture+risk+prediction+in+postmenopausal+women+from+GO+Study%3A+the+comparison+between+FRAX%2C+Garvan%2C+and+POL-RISK+algorithms&rft.jtitle=Archives+of+osteoporosis&rft.au=Pluskiewicz%2C+W.&rft.au=Werner%2C+A.&rft.au=Bach%2C+M.&rft.au=Adamczyk%2C+P.&rft.date=2024-05-16&rft.issn=1862-3514&rft.eissn=1862-3514&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1007%2Fs11657-024-01392-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11657_024_01392_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1862-3514&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1862-3514&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1862-3514&client=summon